DACIT device for axon cancer cell interaction testing in 2D and 3D

Peripheral innervation is increasingly recognized as a critical regulator of tumor progression, yet <i>in vitro</i> models that enable controlled study of axon-cancer cell interactions remain limited. Here, we present the Device for Axon-Cancer cell Interaction Testing in 2D and 3D (DACIT), a microfluidic platform that spatially separates neuronal somas from axons and cancer cells. This configuration supports experimental designs where compartments can be exposed to either identical or distinct conditions. Moreover, the channel height allows the incorporation and monitoring of tumor spheroids, enabling quantification of tumor growth and 3D invasion. We demonstrate DACIT compatibility with common cellular assays, including immunofluorescence, invadopodia assays, pharmacological perturbations, live-cell imaging, and 3D spheroid invasion. Together, these features establish DACIT as a versatile tool to interrogate how peripheral axons influence cancer cell behavior.

Authors

Institutions

Publication Details

Journal
iScience
Published
2025-12-26
DOI
https://doi.org/10.1016/j.isci.2025.114557
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DACIT device for axon cancer cell interaction testing in 2D and 3D

Inés Velázquez-Quesada, Bojana Gligorijevic, Natasha Hesketh, Erkan Tüzel et al.
iScience
3D Printing in Biomedical Research
article

DACIT device for axon cancer cell interaction testing in 2D and 3D

Inés Velázquez-Quesada, Bojana Gligorijevic, Natasha Hesketh, Erkan Tüzel, Svetllana Kallogjerovic, Kara Allison, Xiaotian Zhang, Vahid Alizadeh, Gareth Thomas, Elizaveta Belova
article en

Abstract

Peripheral innervation is increasingly recognized as a critical regulator of tumor progression, yet <i>in vitro</i> models that enable controlled study of axon-cancer cell interactions remain limited. Here, we present the Device for Axon-Cancer cell Interaction Testing in 2D and 3D (DACIT), a microfluidic platform that spatially separates neuronal somas from axons and cancer cells. This configuration supports experimental designs where compartments can be exposed to either identical or distinct conditions. Moreover, the channel height allows the incorporation and monitoring of tumor spheroids, enabling quantification of tumor growth and 3D invasion. We demonstrate DACIT compatibility with common cellular assays, including immunofluorescence, invadopodia assays, pharmacological perturbations, live-cell imaging, and 3D spheroid invasion. Together, these features establish DACIT as a versatile tool to interrogate how peripheral axons influence cancer cell behavior.

iScienceVol. 29(2)
Fox Chase Cancer Center (US), Temple University (US)
Openalex Percentile: Top 42%
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

DACIT device for axon cancer cell interaction testing in 2D and 3D — Inés Velázquez-Quesada, Bojana Gligorijevic, et al. · iScience (2025) | TGRS Research Map | TGRS